Berenberg Bank set a €116.00 ($136.47) price target on Merck KGaA (FRA:MRK) in a report issued on Monday. The brokerage currently has a buy rating on the healthcare company’s stock.

MRK has been the subject of several other research reports. Goldman Sachs Group, Inc. (The) set a €105.00 ($123.53) price objective on shares of Merck KGaA and gave the company a neutral rating in a research note on Tuesday, September 19th. Citigroup Inc. set a €123.00 ($144.71) price objective on shares of Merck KGaA and gave the company a buy rating in a research note on Monday, September 25th. Kepler Capital Markets set a €119.00 ($140.00) price objective on shares of Merck KGaA and gave the company a buy rating in a research note on Thursday, September 21st. DZ Bank AG reaffirmed a sell rating on shares of Merck KGaA in a research note on Tuesday, July 18th. Finally, Warburg Research set a €116.00 ($136.47) price objective on shares of Merck KGaA and gave the company a neutral rating in a research note on Friday, July 7th. Thirteen investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock has a consensus rating of Hold and an average price target of €109.43 ($128.75).

Shares of Merck KGaA (FRA MRK) opened at 95.569 on Monday. The stock’s 50 day moving average is €94.96 and its 200-day moving average is €101.84. Merck KGaA has a one year low of €89.00 and a one year high of €115.00. The company has a market cap of €41.55 billion and a P/E ratio of 24.914.

COPYRIGHT VIOLATION WARNING: This piece was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/06/merck-kgaa-mrk-given-a-116-00-price-target-by-berenberg-bank-analysts-2.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.